Retractable Technologies (RVP)
XASE:RVP
RVP Stock Chart & Stats
$0.73
>-$0.01(-0.49%)
At close: 4:00 PM EST
$0.73
>-$0.01(-0.49%)
Day’s Range― - ―
52-Week Range$0.62 - $1.14
Previous CloseN/A
Volume39.25K
Average Volume (3M)153.51K
Market Cap
$20.58M
Enterprise Value$18.36M
Total Cash (Recent Filing)$36.97M
Total Debt (Recent Filing)$365.28K
Price to Earnings (P/E)―
Beta0.49
Next Earnings
May 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding29,937,159
10 Day Avg. Volume341,920
30 Day Avg. Volume153,511
Financial Highlights & Ratios
PEG Ratio-0.25
Price to Book (P/B)0.31
Price to Sales (P/S)0.60
P/FCF Ratio-3.04
Enterprise Value/Market Cap0.89
Enterprise Value/Revenue0.48
Enterprise Value/Gross Profit390.22
Enterprise Value/Ebitda-2.07
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Balance SheetVery low debt and a relatively sizeable equity base provide durable financial flexibility despite operating losses. Low leverage reduces bankruptcy and refinancing risk, allowing the company to fund operations, manage tariffs, or pursue restructuring without immediate debt pressure.
Established Safety-device Product PortfolioA focused franchise in retractable safety syringes and related devices targets long-term, regulation-driven demand from healthcare providers. Product relevance to needlestick prevention creates recurring per-unit demand and positions the firm to benefit from continued safety regulation adoption across hospitals and clinics.
Recent Revenue Recovery And International GrowthTop-line improvement and strong international expansion indicate market traction and geographic diversification. Durable growth outside the core market can reduce dependence on any single region, help absorb domestic demand normalization, and support longer-term unit-volume recovery if maintained.
Bears Say
Sustained Losses And Margin ErosionMulti-year swing from prior profitability to sustained net losses and compressed or negative gross margins signals structural cost or pricing issues. Persistent negative margins undermine reinvestment capacity, weaken returns, and make a durable earnings recovery more difficult without significant operational change.
Negative Operating And Free Cash FlowRecent cash burn after a prior rebound creates ongoing liquidity pressure that can force asset sales, dilutive financing, or reduced investment in manufacturing and go-to-market activities. Negative FCF over consecutive years materially increases execution risk and limits strategic optionality.
Material Tariff Exposure On China-sourced ProductsSevere tariff exposure is a structural cost headwind that materially raises COGS and compresses margins if supply chains remain China-dependent. Persistent trade-policy risk can force price increases, margin dilution, or costly supply-chain realignment with long lead times and capital requirements.
Retractable Technologies News
RVP FAQ
What was Retractable Technologies’s price range in the past 12 months?
Retractable Technologies lowest stock price was $0.62 and its highest was $1.14 in the past 12 months.
What is Retractable Technologies’s market cap?
Retractable Technologies’s market cap is $20.58M.
When is Retractable Technologies’s upcoming earnings report date?
Retractable Technologies’s upcoming earnings report date is May 18, 2026 which is in 42 days.
How were Retractable Technologies’s earnings last quarter?
Retractable Technologies released its earnings results on Mar 26, 2026. The company reported -$0.08 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.08.
Is Retractable Technologies overvalued?
According to Wall Street analysts Retractable Technologies’s price is currently Overvalued.
Does Retractable Technologies pay dividends?
Retractable Technologies does not currently pay dividends.
What is Retractable Technologies’s EPS estimate?
Retractable Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Retractable Technologies have?
Retractable Technologies has 29,937,159 shares outstanding.
What happened to Retractable Technologies’s price movement after its last earnings report?
Retractable Technologies reported an EPS of -$0.08 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.146%.
Which hedge fund is a major shareholder of Retractable Technologies?
Currently, no hedge funds are holding shares in RVP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Retractable Technologies
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
Technical Analysis
Orasure Technologies
―
Stereotaxis
―
Milestone Scientific
―
Sanara MedTech
―
Sharps Technology, Inc.
―
Ownership Overview
55.66% Insiders
2.55% Mutual Funds
2.84% Other Institutional Investors
37.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---